Home/ Stocks/ LTRN

Lantern Pharma Inc. Common Stock

LTRN XNAS

$0.57 +0.03 (+5.28%) ▲ 15-min delayed

Open

$0.55

High

$0.58

Low

$0.50

Volume

101.5K

Market Cap

$8.48M

About Lantern Pharma Inc. Common Stock

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 16 Website →

Related Market News

No specific coverage for LTRN yet. Check out our latest market news or earnings calendar.

Get LTRN Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Lantern Pharma Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.